CMX Caremark RX

At today�s JP Morgan 25th Annual Healthcare Conference, Mac Crawford, Chairman, President and CEO of Caremark Rx, Inc. (NYSE: CMX) reiterated Caremark�s strong commitment to the CVS/Caremark transaction and emphasized the benefits of the merger with CVS to shareholders. �The CVS/Caremark combination will provide our customers and consumers with exactly what they�ve been asking for: direct contact and access to pharmacists and/or clinicians, and the ability to get the most value for their healthcare dollar,� said Crawford. �Our clients are eager to hear more about the new products and services that will be available to them upon completion of the CVS/Caremark merger.� Mr. Crawford stressed that a CVS/Caremark merger provides for: Significant strategic benefits Financial benefits that are concrete Expected first quarter close, ensuring minimal business disruption CVS/Caremark would have a strong financial position, with low leverage and strong cash flow generation that will give the company financial flexibility. This will allow the new company to consider such options as dividends and share buybacks. �The Caremark and CVS management teams have great experience in handling mergers with significant size and scale. We strongly believe that the CVS/Caremark combination will offer near and long-term benefits for our shareholders, customers and consumers. We are committed to making this work.� Mr. Crawford concluded today�s presentation by recommending shareholders to vote in favor of the merger agreement with CVS Corporation. About Caremark Caremark is a leading pharmaceutical services company, providing through its affiliates comprehensive drug benefit services to over 2,000 health plan sponsors and their plan participants throughout the U.S. The company's clients include corporate health plans, managed care organizations, insurance companies, unions, government agencies and other funded benefit plans. In addition, Caremark is a national provider of drug benefits to eligible beneficiaries under the Medicare Part D program. The company operates a national retail pharmacy network with over 60,000 participating pharmacies, seven mail service pharmacies, the industry's only FDA-regulated repackaging plant and 21 licensed specialty pharmacies for delivery of advanced medications to individuals with chronic or genetic diseases and disorders. Additional information about Caremark is available at www.Caremark.com.